Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7181-7196
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7181
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7181
Cluster | HMEX | HUSA | HSA | Hnon-Hispanic |
F1a | 8.63 | 8.89 | 8.70 | 8.51 |
(8.11-9.9) | (8.16-9.5) | (8.5-8.8) | (8.22-8.91) | |
F1b | 8.63 | 8.88 | 8.59 | 8.49 |
(8.22-10.1) | (8.04-9.86) | (8.19-9.39) | (8.04-9.31) | |
F2 | 8.07 | 8.83 | 8.77 | 7.9 |
(7.59-9.66) | (8.04-9.86) | (8.09-8.24) | (7.66-8.48) | |
F3 | 7.84 | 7.76 | 7.94 | 7.69 |
(7.17-9.91) | (7.28-8.94) | (7.24-8.97) | (7.24-8.82) | |
F4 | 8.36 | 8.66 | 8.50 | 8.29 |
(7.77-10.40) | (7.84-9.98) | (8.06-9.34) | (7.91-9.33) |
Ref. | Country | Study population | n | HBsAg | Anti-HBc | HBV genotypes1 | Diagnosis | ||||||
Positive | A | B | C | D | F | G | H | ||||||
Cortes-Mancera et al[130], 2011 | Colombia | Patients with end-stage liver disease | 131 | 14 (11) | 6 (5) | - | - | - | - | 7 (100) | - | - | Cirrhosis in 71% |
F1a, F3 | HCC in 12%; | ||||||||||||
Cirrhosis and HCC in 17% | |||||||||||||
Devesa et al[131], 2008 | HBV-infected patients | 100 | NA | NA | 2 (2) | - | 2 (2) | 8 (8) | 86 (86) | 2 (2) | - | NA | |
F3 | |||||||||||||
Alvarado Mora et al[58], 2011 | Blood donors | 143 | 143 (100) | NA | 8 (15) | - | - | - | 40 (77) | 8 (15) | - | NA | |
Nakano et al[134], 2001 | Venezuela | Amerindian | 12 | 12 (100) | NA | - | - | - | - | 12 (100) | - | - | CH in 33% |
Quintero et al[132], 2002 | Afro-Venezuelan | 222 | 8 (4) | NA | 3 (50) | - | - | - | 3 (50) | - | - | CH in 100% | |
Gutierrez et al[138], 2004 | Blood donors | 258 | 2 (0.8) | 258 (100) | 1 (9) | - | - | 7 (64) | 3 (27) | - | - | OHB in 4.3%; Rare severe liver disease | |
Kato et al[123], 2005 | HBV-infected patients | 2 | NA | NA | - | - | - | - | 2 (100) | - | - | AH in 100% | |
F1 | |||||||||||||
Devesa et al[131], 2008 | Amerindian | 89 | NA | NA | 3 (3) | - | - | 5 (6) | 81 (91) | - | - | NA | |
F1; F2a; F2b; F3 | |||||||||||||
Cardona et al[135], 2011 | Amerindian | 70 | 2 (3) | 25 (36) | - | - | - | - | 25 (100) | - | - | OHB in 34%; | |
F3 | |||||||||||||
Palumbo et al[133], 2007 | Ecuador | Immigrants in Italy | 2 | 2 (100) | 0 (0) | 2 (100) | - | - | - | - | - | - | CH in 100% |
Casey et al[139], 1996 | Peru | Military personnel | 84 | 77 (88) | 84 (95) | - | - | - | - | 15 (100) | - | - | CH in 68% |
Von Meltzer et al[140], 2008 | HBV-infected patients | 9 | 9 (100) | NA | - | - | - | - | 9 (9) | - | - | CH in 100% | |
F1b | |||||||||||||
Sitnik et al[143], 2004 | Brazil | HBV-infected patients | 103 | 103 (100) | NA | 51 (49) | 3 (3) | 14 (14) | 25 (24) | 10 (10) | - | - | CH in 100% |
Palumbo et al[133], 2007 | Immigrants in Italy | 12 | 12 (100) | 0 (0) | 3 (25) | - | - | 9 (75) | - | - | - | CH in 100% | |
Bertolini et al[144], 2012 | Blood donors | 228 | 228 (100) | NA | 32 (14) | - | 3 (1) | 189 (83) | 3 (1) | - | 1 (0.4) | NA | |
A1, A2 | F2a, F4 | ||||||||||||
Mello et al[102], 2013 | HBV-infected patients | 12 | NA | NA | - | - | - | - | 12 (100) F2a, F1b, F4 | - | - | NA | |
Eloy et al[145], 2013 | HBV-infected patients | 119 | 80 (100) | 80 (100) | 74 (92) | - | 4 (5) | 1 (1) | 1 (1) | - | - | Asymp in 70; AH in 2%; CH in 28% | |
Araujo et al[146], 2013 | HBV/HIV-coinfected patients | 1 | 1 (100) | 1 (100) | - | - | - | - | 1 (100) | 1 | - | CH in 100% | |
F4 | -100 | ||||||||||||
Khan et al[147], 2008 | Bolivia | Japanese immigrants | 287 | 10 (8) | NA | - | 1 (1) | 5 (50) | - | 4 (4) | - | - | NA |
Ba | C2 | ||||||||||||
Khan et al[147], 2008 | Native population | 200 | 12 (6) | NA | - | 1 (8) | 3 (25) | - | 8 (68); F4 | - | - | NA | |
Di Lello et al[141], 2009, | Chile | HBV-infected patients | 40 | NA | NA | 3 (7) | 2 (5) | 3 (7) | - | 27 (67) | - | - | NA |
Venegas et al[142],2011 | HBV-infected patients | 21 | 21 (100) | 21 (100) | - | - | - | - | 21 (100) | - | - | CH in 100% | |
F1b | |||||||||||||
Solari et al[149], 2009 | Argentina | HBV-infected patients | 21 | 21 (100) | - | 8 (38) | 3 (14) | - | 3 (14) | 7 (33) | - | - | CH in 100% |
Pezzano et al[150], 2011 | HBV-infected patients | 139 | 128 (100) | 128 (100) | 22 (28) | 1 (0.8) | 3 (2) | 28 (22) | 60 (47) | - | - | AH in 37%; CH in 63% | |
Trinks et al[148], 2012 | HBV-infected patients | 33 | 33 (100) | 33 (100) | 15 (45) A1, A2 | - | - | 2 (6) | 13 (39) | - | - | CH in 100% | |
D1 | F1b, F4 | ||||||||||||
Barbini et al[101], 2013 | HBV-infected patients | 29 | 29 (100) | 29 (100) | 4 (14) A2 | - | - | 2 (7) D2, D3 | 20 (62) | 2 (7) | - | CH in 100% | |
F1b, F4 | |||||||||||||
Araujo et al[146], 2013 | HBV/HIV-coinfected patients | 1 | 1 (100) | 1 (100) | - | - | - | - | 1 (100); F1b | 1 | - | CH in 100% | |
-100 |
Ref. | Country | Study population | n | HBsAg | Anti-HBc | HBV genotypes1 | Diagnosis | |||||||
Positive | A | B | C | D | E | F | G | H | ||||||
Sanchez et al[107], 2002 | Mexico | HBV-infected adults | 15 | 13 (87) | 6 (40) | 3 (20) | - | - | 1 (7) | - | 10 (67) | 1 (7) | - | AH in 30%; |
CH in 27%; | ||||||||||||||
cirrhosis in 7%. | ||||||||||||||
Sanchez et al[50], 2007 | HBV-infected patients | 67 | 67 (100) | NA | 10 (15) | - | - | 4 (6) | 4 (6) | 44 (66) | AH in 15%; | |||
CH in 48% | ||||||||||||||
Ruiz-Tachiquin et al[151], 2007 | Blood donors and HBV-infected patients | 33 | 33 (100) | NA | - | - | 4 (12) | 1 (3) | - | 26 (79) | Asymp in 64%; CH in 36% | |||
Roman et al[98], 2010 | Native adults | 306 | 17 (5.6) | 100 (32.7) | 6 (24) | 1 (4) | 2 (8) | 4 (16) | - | 1 (4) | 11 (44) | OHB in 14.2%; asymp in 100% | ||
Arauz-Ruiz et al[115], 1997 | Central America: | HBV-infected patients, blood donors and pregnant woman | 330 | 330 (100) | 71 (21) | 13 (14) | - | 1 (1) | 5 (6) | 71 (79) | - | CH in 21%; | ||
Costa Rica, Nicaragua, | F1a; F1b; F2 | AH in 16% | ||||||||||||
Honduras, El Salvador, Guatemala | ||||||||||||||
Leon et al[122], 2005 | Costa Rica | HBV-infected patients | 50 | 32 (64) | 18 (36) | - | - | - | 2 (4) | - | 48 (96) | - | CH in 47%; | |
HCC in 16% | ||||||||||||||
Kato et al[123], 2005 | Panama | HBV-infected patients | 2 | NA | NA | - | - | - | - | 2 (100) | - | - | NA | |
F1, F3 | ||||||||||||||
Martinez et al[124], 2013 | Chinese residents | 320 | 42 (13) | - | 11 (61) | 7 (39) | - | - | - | - | - | No evident liver disease | ||
B2 | C1 | |||||||||||||
Andernach et al[125], 2009 | Haití | Pregnant woman | 320 | 320 (100) | 128 (71) | - | - | 40 (22) | 11 (6) | - | - | - | NA | |
A1, A2, A5 | D3, D4 | |||||||||||||
Couto et al[126], 2013 | Haitian’s in South Florida | 27 | NA | NA | - | - | - | 19 (79) | - | - | - | - | NA |
- Citation: Roman S, Jose-Abrego A, Fierro NA, Escobedo-Melendez G, Ojeda-Granados C, Martinez-Lopez E, Panduro A. Hepatitis B virus infection in Latin America: A genomic medicine approach. World J Gastroenterol 2014; 20(23): 7181-7196
- URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7181.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i23.7181